行情

IGC

IGC

India全球化资本
AMEX

实时行情|Nasdaq Last Sale

1.420
-0.080
-5.33%
盘后: 1.430 +0.01 +0.70% 19:27 04/16 EDT
开盘
1.500
昨收
1.500
最高
1.504
最低
1.381
成交量
152.12万
成交额
--
52周最高
4.500
52周最低
0.4500
市值
5,865.22万
市盈率(TTM)
-6.3563
分时
5日
1月
3月
1年
5年
BZ NOTE星期一后，DC市长的Doc显示资金已用于大麻合法化法案（有关背景，请参阅本标题的正文）
A member of Benzinga's cannabis newsdesk responded to trader circulation of the doc and the resulting price action in cannabis stocks: ""A federal agency says a spending rider that prevents DC from
Benzinga · 03/09 13:56
IGC获得另一种基于大麻的治疗疼痛的专利
India Globalization Capital, Inc. (the “Company”) (NYSE American: IGC) announced today that on March 2, 2021, the Company received one more patent...
BusinessWire - BZX · 03/08 23:33
Igc对阿尔茨海默氏病患者的1期临床试验的简要更新
reuters.com · 02/22 14:14
印度全球化资本强调了阿尔茨海默氏症1期临床试验的进展； 2月11日说，完成了三个给药级别中的第一个，并继续招募剩余患者
India Globalization Capital, Inc. ("IGC" or the "Company") (NYSE:IGC) is pleased to announce the progress of its tetrahydrocannabinol (THC)-based phase 1 clinical trial, which was approved to proceed
Benzinga · 02/22 13:02
IGC对阿尔茨海默氏病患者的1期临床试验的最新进展
India Globalization Capital, Inc. (“IGC” or the “Company”) (NYSE American: IGC) is pleased to announce the progress of its tetrahydrocannabinol (THC)-based...
BusinessWire - BZX · 02/22 13:00
10-Q：印度全球化资本有限公司
(EDGAR Online via COMTEX) -- Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations The purpose of this Management's...
Edgar Online - (EDG = 10Q, 10K) · 02/16 11:11
印度全球化资本3Q修订版$ 108,000> IGC
India Globalization Capital 3Q Rev $108,000 >IGC
Dow Jones · 02/13 00:00
印度全球化资本3Qs / Shr 6c> IGC
India Globalization Capital 3Q Loss/Shr 6c >IGC
Dow Jones · 02/13 00:00
更多
财务预测
暂无数据
利润表更多
净利润（美元）
同比（%）
资产负债表更多
总资产（美元）
总负债（美元）
资产负债率（%）
现金流表更多
经营现金流（美元）
同比（%）
了解IGC最新的财务预测，通过IGC每股收益，每股净资产，每股现金流等数据分析India全球化资本近期的经营情况，然后做出明智的投资选择。
暂无数据
  • 业绩
  • 资产分布
  • 分红历史
暂无数据
所属板块
商业支持服务
-0.50%
专业与商业服务
+0.10%
高管信息
Chairman/Independent Director
Richard Prins
Chief Financial Officer/Vice President
Claudia Grimaldi
Chief Accounting Officer
Rohit Goel
Director
John Lynch
暂无数据
  • 全部
  • 财务报告
  • 内部人交易
更多
IGC 简况
India Globalization Capital, Inc. develops intellectual property for the treatment of life altering or life threatening conditions, through its research on phytocannabinoid-based therapies, in the United States. The Company also builds farming facilities for leasing. In Malaysia, the Company develops and manages residential and commercial real estate. In India, it leases heavy equipment. It is also focused on developing, testing and patenting phytocannabinoid-based pharmaceutical therapies and becoming a specialty pharmaceutical provider of phytocannabinoid-based pharmaceutical and nutraceutical products. It is developing a product portfolio of phytocannabinoid-based therapies for indications, including neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis. In Malaysia, the Company’s subsidiary, Cabaran Ultima Sdn. Bhd., is focused on building a five-star hotel, Genting highlands.

微牛提供India Globalization Capital, Inc.(AMEX-IGC)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的IGC股票新闻，以帮助您做出投资决策。

模拟交易：模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易IGC股票基本功能。